CLGN
Income statement / Annual
Last year (2023), CollPlant Biotechnologies Ltd.'s total revenue was $10.96 M,
an increase of 3,565.22% from the previous year.
In 2023, CollPlant Biotechnologies Ltd.'s net income was -$7.02 M.
See CollPlant Biotechnologies Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$10.96 M
|
$299,000.00
|
$15.64 M
|
$6.14 M
|
$2.32 M
|
$4.79 M
|
$479,917.00
|
$75,911.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.99 M |
$400,000.00 |
$2.01 M |
$3.00 M |
$1.88 M |
$378,630.00 |
$14,961.00 |
$225,072.00 |
$202,819.00 |
$0.00 |
| Gross Profit |
$8.97 M |
-$101,000.00 |
$13.64 M |
$3.14 M |
$439,000.00 |
$4.41 M |
$464,956.00 |
-$149,161.00 |
-$202,819.00 |
$0.00 |
| Gross Profit Ratio |
0.82 |
-0.34 |
0.87 |
0.51 |
0.19 |
0.92 |
0.97 |
-1.96 |
0 |
0 |
| Research and Development
Expenses |
$10.48 M
|
$10.26 M
|
$7.63 M
|
$4.07 M
|
$4.41 M
|
$5.16 M
|
$4.05 M
|
$4.36 M
|
$3.04 M
|
$2.50 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$4.62 M
|
$3.62 M
|
$3.29 M
|
$2.38 M
|
$2.86 M
|
$1.77 M
|
$945,060.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$48,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$42,373.00
|
| Selling, General &
Administrative Expenses |
$6.00 M
|
$6.74 M
|
$5.94 M
|
$4.67 M
|
$3.62 M
|
$3.29 M
|
$2.38 M
|
$2.86 M
|
$1.77 M
|
$987,434.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$33,000.00 |
$21,507.00 |
$13,522.00 |
$9,878.85 |
$6,404.25 |
$15,665.00 |
| Operating Expenses |
$16.48 M |
$17.00 M |
$13.57 M |
$8.73 M |
$8.07 M |
$8.48 M |
$6.44 M |
$7.24 M |
$4.82 M |
$3.50 M |
| Cost And Expenses |
$18.47 M |
$17.40 M |
$15.58 M |
$11.74 M |
$9.95 M |
$8.85 M |
$6.45 M |
$7.24 M |
$4.82 M |
$3.50 M |
| Interest Income |
$788,000.00 |
$321,000.00 |
$219,000.00 |
$40,000.00 |
$10,000.00 |
$438,107.00 |
$72,793.00 |
$0.00 |
$0.00 |
$8,988.35 |
| Interest Expense |
$10,000.00 |
$34,000.00 |
$37,000.00 |
$34,000.00 |
$63,000.00 |
$15,134.00 |
$21,579.00 |
$33,482.14 |
$13,064.00 |
$6,420.25 |
| Depreciation &
Amortization |
$1.10 M
|
$1.08 M
|
$773,000.00
|
$660,000.00
|
$539,000.00
|
$342,000.00
|
$291,633.00
|
$225,072.00
|
$201,861.00
|
$205,961.00
|
| EBITDA |
-$6.41 M
|
-$16.02 M
|
$838,000.00
|
-$4.94 M
|
-$7.09 M
|
-$3.90 M
|
-$5.73 M
|
-$6.95 M
|
-$4.60 M
|
-$3.41 M
|
| EBITDA Ratio |
-0.58 |
-53.58 |
0.05 |
-0.8 |
-1.57 |
-0.69 |
-11.84 |
-92.36 |
0 |
0 |
| Operating Income Ratio
|
-0.69
|
-57.18
|
0
|
-0.91
|
-3.29
|
-0.85
|
-12.44
|
-94.33
|
0
|
0
|
| Total Other
Income/Expenses Net |
$493,000.00
|
$172,000.00
|
$172,000.00
|
-$175,000.00
|
-$3.53 M
|
-$2.00 M
|
-$94,000.00
|
-$101,993.84
|
$50,867.00
|
$156,320.00
|
| Income Before Tax |
-$7.02 M |
-$16.93 M |
$237,000.00 |
-$5.77 M |
-$11.16 M |
-$3.69 M |
-$6.01 M |
-$7.25 M |
-$4.78 M |
-$3.34 M |
| Income Before Tax Ratio
|
-0.64
|
-56.61
|
0.02
|
-0.94
|
-4.82
|
-0.77
|
-12.52
|
-95.52
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$172,000.00 |
-$172,000.00 |
$34,000.00 |
$3.53 M |
$2.96 M |
$28,442.00 |
-$86,281.19 |
$63,854.00 |
$162,836.00 |
| Net Income |
-$7.02 M |
-$16.75 M |
$409,000.00 |
-$5.81 M |
-$14.70 M |
-$6.25 M |
-$6.05 M |
-$7.24 M |
-$4.79 M |
-$3.34 M |
| Net Income Ratio |
-0.64 |
-56.03 |
0.03 |
-0.95 |
-6.34 |
-1.31 |
-12.61 |
-95.37 |
0 |
0 |
| EPS |
-0.62 |
-1.52 |
0.041 |
-0.84 |
-2.95 |
-1.43 |
-2.27 |
-3.6 |
-2.83 |
-2.08 |
| EPS Diluted |
-0.62 |
-1.52 |
0.0342 |
-0.84 |
-2.95 |
-1.43 |
-2.27 |
-3.6 |
-2.83 |
-2.08 |
| Weighted Average Shares
Out |
$11.39 M
|
$11.03 M
|
$9.97 M
|
$6.89 M
|
$4.99 M
|
$4.38 M
|
$2.66 M
|
$2.01 M
|
$1.69 M
|
$1.61 M
|
| Weighted Average Shares
Out Diluted |
$11.39 M
|
$11.03 M
|
$11.97 M
|
$6.89 M
|
$4.99 M
|
$4.38 M
|
$2.66 M
|
$2.01 M
|
$1.69 M
|
$1.61 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
